Expanded Access Program to Provide Bamlanivimab (LY3819253) for the Treatment of COVID-19
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL
- Status
- COMPLETED
- Phase
- PHASE2
Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
A Study of LY3509754 in Healthy Non-Japanese and Japanese Participants
- Status
- TERMINATED
- Phase
- PHASE1
A Study of LY3537021 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of LY3522348 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ramucirumab (LY3009806) Given by Injection Under the Skin in Participants With Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Compare Two Different Formulations of Mirikizumab in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Osimertinib and Abemaciclib in EGFR Mutant Non-Small Cell Lung Cancer After Osimertinib Resistance
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety & Efficacy of Encapsulated Allogeneic FVIII Cell Therapy in Haemophilia A
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin
- Status
- COMPLETED
- Phase
- PHASE3
A Study of LY3819253 (LY-CoV555) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib.
- Status
- TERMINATED
- Phase
- PHASE2
Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Chronic Low Back Pain
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
ACTIV-2: A Study for Outpatients With COVID-19
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3